|
| Item Number: |
590 |
| Industry: |
Therapeutic
|
| Category: |
Cardiovascular / Haematology, Gene Therapy
|
| Development Stage: |
Early Stage
|
| Organisation Type: |
University
|
| Country: |
South Korea
|
| Business Opportunity: | Out-Licensing, Technology Transfer, Collaboration R&D |
DESCRIPTION
Using the gene scissors (TALEN) to model the world's first hemophilic disease in degenerated stem cells
First mutant gene correction using CRISPR / Cas9 in iPS cells of patients
- Corrected cells had no nonspecific mutations / Identify the validation in hemophilia mouse model
- Identify the possibility of cell therapy through self-transplantation
Features & Contact
Sign in and you'll be able to send enquiries about this item, view full details and save it
SIGN IN
|
